MLICM
DXCM icon

Metropolitan Life Insurance Company (MetLife)’s DexCom DXCM Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,548
Closed -$2.16M – 629
2024
Q1 		$2.16M Sell
15,548
-178
-1% -$22.4K 0.09% 187
2023
Q4 		$1.95M Sell
15,726
-321
-2% -$32.8K 0.09% 187
2023
Q3 		$1.5M Sell
16,047
-845
-5% -$95.3K 0.08% 226
2023
Q2 		$2.17M Sell
16,892
-391
-2% -$47.3K 0.11% 161
2023
Q1 		$2.01M Sell
17,283
-4,150
-19% -$465K 0.1% 180
2022
Q4 		$2.43M Sell
21,433
-1,108
-5% -$122K 0.11% 184
2022
Q3 		$1.82M Sell
22,541
-273
-1% -$23.1K 0.09% 227
2022
Q2 		$1.7M Sell
22,814
-298
-1% -$27.2K 0.07% 254
2022
Q1 		$2.96M Sell
23,112
-38,328
-62% -$4.19M 0.11% 183
2021
Q4 		$8.25M Sell
61,440
-1,400
-2% -$201K 0.11% 141
2021
Q3 		$8.59M Sell
62,840
-2,072
-3% -$261K 0.12% 130
2021
Q2 		$6.93M Sell
64,912
-624
-1% -$59.9K 0.1% 162
2021
Q1 		$5.89M Sell
65,536
-3,764
-5% -$353K 0.09% 178
2020
Q4 		$6.41M Sell
69,300
-2,632
-4% -$235K 0.1% 161
2020
Q3 		$7.41M Sell
71,932
-1,292
-2% -$135K 0.13% 134
2020
Q2 		$7.42M Buy
73,224
+47,820
+188% +$4.28M 0.13% 135
2020
Q1 		$1.71M Sell
25,404
-800
-3% -$49.8K 0.04% 443
2019
Q4 		$1.43M Sell
26,204
-488
-2% -$23.1K 0.02% 716
2019
Q3 		$996K Buy
26,692
+944
+4% +$36.7K 0.02% 857
2019
Q2 		$965K Sell
25,748
-596
-2% -$18.7K 0.02% 918
2019
Q1 		$784K Sell
26,344
-548
-2% -$19.3K 0.01% 1020
2018
Q4 		$805K Sell
26,892
-88
-0.3% -$2.79K 0.02% 927
2018
Q3 		$965K Sell
26,980
-536
-2% -$16.6K 0.02% 954
2018
Q2 		$653K Buy
27,516
+1,944
+8% +$41.2K 0.01% 1137
2018
Q1 		$474K Buy
25,572
+12
+0% +$177 0.01% 1313
2017
Q4 		$367K Sell
25,560
-244
-0.9% -$3.17K ﹤0.01% 1486
2017
Q3 		$316K Buy
25,804
+1,316
+5% +$23.3K ﹤0.01% 2000
2017
Q2 		$448K Buy
24,488
+1,912
+8% +$35.3K ﹤0.01% 1779
2017
Q1 		$478K Hold
22,576
– – ﹤0.01% 1674
2016
Q4 		$337K Sell
22,576
-1,024
-4% -$18.1K ﹤0.01% 2017
2016
Q3 		$517K Sell
23,600
-1,132
-5% -$25.2K ﹤0.01% 1684
2016
Q2 		$490K Buy
24,732
+956
+4% +$16.3K ﹤0.01% 1719
2016
Q1 		$404K Hold
23,776
– – ﹤0.01% 1718
2015
Q4 		$487K Buy
23,776
+636
+3% +$13.2K ﹤0.01% 1636
2015
Q3 		$497K Hold
23,140
– – ﹤0.01% 1640
2015
Q2 		$463K Sell
23,140
-206,748
-90% -$3.63M ﹤0.01% 1799
2015
Q1 		$3.58M Sell
229,888
-884
-0.4% -$13.4K 0.03% 674
2014
Q4 		$3.18M Hold
230,772
– – 0.02% 752
2014
Q3 		$2.31M Hold
230,772
– – 0.02% 894
2014
Q2 		$2.29M Buy
230,772
+8,168
+4% +$72.4K 0.02% 943
2014
Q1 		$2.3M Hold
222,604
– – 0.02% 912
2013
Q4 		$1.97M Hold
222,604
– – 0.01% 986
2013
Q3 		$1.57M Sell
222,604
-5,896
-3% -$37.4K 0.01% 1050
2013
Q2 		$1.28M Buy
+228,500
New +$1.09M 0.01% 1109

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s DXCM Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of DexCom (DXCM) in Q2 2024, closing a stake of 15,548 shares — an estimated $2.16M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DXCM in Q2 2013 and held it in 44 quarters. The position peaked at $8.59M in Q3 2021. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 15,548 DexCom shares in Q2 2024, an estimated $2.16M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in DexCom in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s DexCom position peaked at $8.59M in Q3 2021.
  • 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.